India to Djibouti Pharmaceutical Export (2026) — $23.7M, 89 Suppliers | TransData Nexus

India to Djibouti Pharmaceutical Export (2026) — $23.7M, 89 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Djibouti

#	Formulation	Value	Share
1	Medroxyprogesterone Acetate - 150mg/ml in 1 ML Vial - Injection (aqueous Suspen…	$4.7M	19.8%
2	Dolutegravir 50 + Lamivudine 300 + Tenof	$4.6M	19.4%
3	Lamivudine 300mg+tenofovir Disoproxil Fumarate 300mg+dolutegravir Sodium 50mg T…	$2.1M	8.8%
4	Aksone (ceftriaxone Injection 1 Gm with	$516.6K	2.2%
5	Patient Kit(forecox Trac) (rifampicin 150mg+isoniazid 75mg+pyrazinamide 400mg+e…	$491.2K	2.1%
6	Aksone ( Mm)	$390.0K	1.6%
7	Electral-zinc Kit- Combipack of Electral21.8 G and Zinc Sulfate Tablets USP 20mg	$325.1K	1.4%
8	Choice Ethiopia Dkt Packs 500000	$242.9K	1.0%
9	Aksone ( Ceftriaxone Injection 1 Gm with	$240.7K	1.0%
10	Contraceptive Based On Other Product Ofheading 2937 Namely Intrauterine Contrac…	$230.6K	1.0%
11	Sterile Ceftriaxone Sodium USP Injection Containing Ceftriaxone Not Less Than 1…	$221.9K	0.9%
12	Revoke1.5,1's,ethiopia	$198.5K	0.8%
13	Medroxyprogesterone Acetate 150mg/ ML in 1ml Vial Injection (aqueous Suspension…	$161.6K	0.7%
14	Pharmaceutical Products Medicine: Pregabalin Capsules 300 MG Pack:	$161.2K	0.7%
15	Human Albumin Solution -20% 100ml (qty:500 Units)	$133.2K	0.6%

India exports 18+ pharmaceutical formulations to Djibouti with a combined trade value of $23.7M. Key products include Dolutegravir ($4.6M), Tenofovir ($1.4M), Ceftriaxone ($517K), Zinc ($325K), Sodium ($222K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 2,076 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Djibouti Trade Routes

1Dolutegravir$4.6M

2Tenofovir$1.4M

3Ceftriaxone$517K

4Zinc$325K

5Sodium$222K

Top Indian Exporters to Djibouti

1Mylan Laboratories Limited

$5.3M

2Hetero Labs Limited

$4.6M

3Macleods Pharmaceuticals Limited

$2.6M

4Akriti Pharmaceuticals Private Limited

$1.3M

5Bluten Pharmaceuticals

Port Analysis — India to Djibouti Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA (INNSA1)6.8%

JNPT2.8%

AHEMDABAD ICD (INSBI6)0.8%

JNPT/ NHAVA SHEVA SEA7.6%

STARTRACK TERMINAL ICD (INSTT6)0.0%

Djibouti Import Ports

DJIBOUTI53.6%

Djibouti37.1%

Addis Ababa0.7%

MOJO ETHIOPIA4.4%

Hargeisa0.5%

Trade Statistics

Total Value$23.7M

Shipments2,076

Indian Exporters89

Djibouti Buyers136

Avg Shipment$11K

Products1,547

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Djibouti Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and Djibouti has experienced significant growth over the past decade. In 2024, India's pharmaceutical exports to Djibouti were valued at approximately $17.16 million, marking a substantial increase from previous years. This upward trajectory reflects the strengthening of bilateral trade relations and India's expanding presence in the East African pharmaceutical market.

Key milestones in this evolution include the establishment of robust supply chains and the recognition of Indian pharmaceutical products for their quality and affordability. The diversification of India's export portfolio, encompassing a wide range of therapeutic areas, has further solidified its position as a preferred supplier to Djibouti. The consistent growth in export value underscores the increasing demand for Indian pharmaceutical formulations in Djibouti.

2India's Market Position

India holds a significant share in Djibouti's pharmaceutical import market, positioning itself as a key supplier among other origins. The strategic importance of this relationship is underscored by India's ability to meet Djibouti's diverse healthcare needs through a comprehensive range of pharmaceutical products. This market position is further enhanced by India's competitive pricing and adherence to international quality standards.

Recent Developments

Djibouti Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in Djibouti must comply with the World Health Organization's Good Manufacturing Practices (WHO-GMP) standards. The registration process involves submitting a comprehensive dossier, typically in the Common Technical Document (CTD) format, which includes detailed information on the product's quality, safety, and efficacy. Bioequivalence studies may be required to demonstrate therapeutic equivalence to the reference product. The timeline for registration can vary, but it generally spans several months, depending on the complexity of the product and the efficiency of the regulatory review process.

2GMP & Facility Requirements

Djibouti mandates that Indian manufacturing sites adhere to WHO-GMP standards. The inspection process involves a thorough evaluation of the manufacturing facilities, quality control systems, and documentation practices to ensure compliance with international standards. While Djibouti may not have a robust domestic pharmaceutical manufacturing base, it relies on international standards to ensure the quality of imported pharmaceutical products. Mutual recognition agreements may facilitate the acceptance of certifications from recognized authorities, streamlining the approval process for Indian exporters.

3Import Documentation

Importing pharmaceutical products into Djibouti requires specific documentation, including an Import License, Certificate of Pharmaceutical Product (CPP), Certificate of Analysis (CoA), and proof of compliance with WHO-GMP standards. Customs procedures involve the submission of these documents for clearance, along with payment of applicable duties and taxes. The efficiency of customs procedures can vary, and exporters should ensure all documentation is accurate and complete to prevent delays.

TransData Nexus Research · Djibouti regulatory databasesMar 2026

FAQ — India to Djibouti Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Djibouti?

India exported pharmaceuticals worth $23.7M to Djibouti across 2,076 verified shipments.

Who are the top Indian pharmaceutical exporters to Djibouti?

1. MYLAN LABORATORIES LIMITED — $5.3M. 2. HETERO LABS LIMITED — $4.6M. 3. MACLEODS PHARMACEUTICALS LIMITED — $2.6M. Total: 89 suppliers.

Which companies in Djibouti import pharmaceuticals from India?

1. COMMERCIAL BANK OF ETHIOPIA, — $4.8M. 2. ETHIOPIAN PHARMACEUTICAL SUPPLY AGE — $2.2M. 3. TO THE ORDER — $723.1K. 136 buyers total.

What pharmaceutical products does India export most to Djibouti?

1. Medroxyprogesterone Acetate - 150mg/ml in 1 ML Vial - Injection (aqueous Suspen… ($4.7M, 19.8%); 2. Dolutegravir 50 + Lamivudine 300 + Tenof ($4.6M, 19.4%); 3. Lamivudine 300mg+tenofovir Disoproxil Fumarate 300mg+dolutegravir Sodium 50mg T… ($2.1M, 8.8%); 4. Aksone (ceftriaxone Injection 1 Gm with ($516.6K, 2.2%); 5. Patient Kit(forecox Trac) (rifampicin 150mg+isoniazid 75mg+pyrazinamide 400mg+e… ($491.2K, 2.1%)

Which ports handle pharmaceutical shipments from India to Djibouti?

Export: NHAVA SHEVA SEA (INNSA1), JNPT, AHEMDABAD ICD (INSBI6), JNPT/ NHAVA SHEVA SEA, STARTRACK TERMINAL ICD (INSTT6). Import: DJIBOUTI, Djibouti, Addis Ababa, MOJO ETHIOPIA, Hargeisa.

Why does Djibouti import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $23.7M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Djibouti?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Djibouti pharmaceutical trade?

$11.4K per consignment across 2,076 shipments.

How many Indian pharmaceutical companies export to Djibouti?

89 Indian companies. Largest: MYLAN LABORATORIES LIMITED with $5.3M.

How can I find verified Indian pharmaceutical suppliers for Djibouti?

TransData Nexus covers 89 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Djibouti identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 2,076 verified shipments from 89 Indian exporters to 136 Djibouti buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

89 Exporters

136 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Djibouti Pharmaceutical Export

Top Pharmaceutical Formulations — India to Djibouti

Top Pharmaceutical Products — India to Djibouti Trade Routes

Top Indian Exporters to Djibouti

Port Analysis — India to Djibouti Pharmaceutical Shipments

Indian Export Ports

Djibouti Import Ports

Trade Statistics

Other Destinations

India–Djibouti Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

Recent Developments

Top Djibouti Buyers from India

Product Routes

Full Dataset Access

Djibouti Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Djibouti

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Djibouti

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Djibouti Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — Djibouti for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Djibouti

1Competing Origins

2India's Competitive Edge

3Challenges & Threats